Bioventus (BVS) FCF Margin (QoQ) (2020 - 2026)
Bioventus (BVS) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Bioventus | 825.05 Mn | 789.21 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -1,732.00 |
| Dec 31, 2025 | 326.00 |
| Sep 27, 2025 | 243.00 |
| Jun 28, 2025 | 3,426.00 |
| Mar 29, 2025 | -2,827.00 |
| Dec 31, 2024 | 451.00 |
| Sep 28, 2024 | -259.00 |
| Jun 29, 2024 | 1,495.00 |
| Mar 30, 2024 | -1,252.00 |
| Dec 31, 2023 | 1,661.00 |
| Sep 30, 2023 | -1,872.00 |
| Jul 1, 2023 | 884.00 |
| Apr 1, 2023 | -750.00 |
| Dec 31, 2022 | 959.00 |
| Oct 1, 2022 | 25.00 |
| Jul 2, 2022 | 1,658.00 |
| Apr 2, 2022 | -2,118.00 |
| Dec 31, 2021 | -297.00 |
| Oct 2, 2021 | -912.00 |
| Jul 3, 2021 | 3,754.00 |